Kuryliszyn-Moskal Anna, Klimiuk Piotr Adrian, Sierakowski Stanisław, Ciołkiewicz Mariusz
Department of Rheumatology and Internal Diseases, Medical University of Białystok, M. Curie-Sklodowskiej 24a, 15-276, Białystok, Poland.
Arch Immunol Ther Exp (Warsz). 2007 May-Jun;55(3):179-85. doi: 10.1007/s00005-007-0017-7. Epub 2007 Jun 8.
The aim of the study was to evaluate whether vascular endothelial growth factor (VEGF) serum level is associated with systemic organ involvement, microvascular changes as determined by nailfold capillaroscopy, and disease activity of systemic lupus erythematosus (SLE).
Serum levels of VEGF were determined by an enzyme-linked immunosorbent assay in 47 SLE patients and in 30 healthy controls. Nailfold capillaroscopy was performed in all patients and healthy subjects.
Morphological changes were observed by nailfold capillaroscopy in 45 of 47 (95.7%) SLE patients. Mild capillary changes were found in 16 (34%), moderate in 21 (44.7%), and severe in 8 (17%) SLE patients. All patients with systemic organ involvement showed severe or moderate changes in nailfold capillaroscopy. In comparison with the control group, a higher serum concentration of VEGF in SLE patients was demonstrated (p<0.05). Furthermore, significant differences in VEGF serum concentration between SLE patients with systemic involvement and controls were found (p<0.01). Comparison between patients with active and inactive SLE according to SLEDAI score showed a significantly higher concentration of VEGF in the sera of patients with active SLE (p<0.01). The SLE patients with severe and moderate changes in nailfold capillaroscopy showed significantly higher VEGF serum levels than SLE patients with mild changes (p<0.05) or healthy controls (p<0.01). Moreover, the VEGF serum level correlated significantly with ESR (r=0.580, p<0.0001) and CRP (r=0.512, p<0.005).
Our data suggest that VEGF serum level may be a useful marker of disease activity and internal organ involvement in SLE patients. Abnormalities in nailfold capillaroscopy may reflect the extent of microvascular involvement and are associated with systemic manifestation in SLE.
本研究的目的是评估血管内皮生长因子(VEGF)血清水平是否与系统性器官受累、甲襞毛细血管镜检查所确定的微血管变化以及系统性红斑狼疮(SLE)的疾病活动度相关。
采用酶联免疫吸附测定法测定47例SLE患者和30例健康对照者的血清VEGF水平。对所有患者和健康受试者进行甲襞毛细血管镜检查。
47例SLE患者中有45例(95.7%)通过甲襞毛细血管镜检查观察到形态学变化。16例(34%)SLE患者出现轻度毛细血管变化,21例(44.7%)为中度,8例(17%)为重度。所有系统性器官受累的患者在甲襞毛细血管镜检查中均显示重度或中度变化。与对照组相比,SLE患者的血清VEGF浓度更高(p<0.05)。此外,发现有系统性受累的SLE患者与对照组之间的VEGF血清浓度存在显著差异(p<0.01)。根据SLEDAI评分对活动期和非活动期SLE患者进行比较,结果显示活动期SLE患者血清中的VEGF浓度显著更高(p<0.01)。甲襞毛细血管镜检查显示重度和中度变化的SLE患者,其血清VEGF水平显著高于轻度变化的SLE患者(p<0.05)或健康对照者(p<0.01)。此外,VEGF血清水平与血沉(ESR)显著相关(r=0.580,p<0.0001),与C反应蛋白(CRP)也显著相关(r=0.512,p<0.005)。
我们的数据表明,VEGF血清水平可能是SLE患者疾病活动度和内脏器官受累的一个有用标志物。甲襞毛细血管镜检查异常可能反映微血管受累程度,并与SLE的全身表现相关。